BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

被引:19
作者
Erturk, Elif [1 ]
Cecener, Gulsah [2 ]
Tezcan, Gulcin [2 ,3 ]
Egeli, Unal [2 ]
Tunca, Berrin [2 ]
Gokgoz, Sehsuvar [4 ]
Tolunay, Sahsine [5 ]
Tasdelen, Ismet [4 ]
机构
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Dept Med Biol, Fac Med, Bursa, Turkey
[3] Uludag Univ, Inst Hlth Sci, Dept Med Biol, Bursa, Turkey
[4] Uludag Univ, Dept Gen Surg, Fac Med, Bursa, Turkey
[5] Uludag Univ, Dept Pathol, Fac Med, Bursa, Turkey
关键词
Triple negative breast cancer; MicroRNA; BRCA1/2 gene mutations; miR-200c; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; OVARIAN-CANCER; FEEDBACK LOOP; FAMILY; ZEB1; MICRORNA-200C; PROGRESSION; METASTASIS; RESISTANCE;
D O I
10.1016/j.gene.2014.11.047
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 69 条
[1]  
Abeliovich D, 1997, AM J HUM GENET, V60, P505
[2]   miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [J].
Adam, Liana ;
Zhong, Meng ;
Choi, Woonyoung ;
Qi, Wei ;
Nicoloso, Milena ;
Arora, Ameeta ;
Calin, George ;
Wang, Hua ;
Siefker-Radtke, Arlene ;
McConkey, David ;
Bar-Eli, Menashe ;
Dinney, Colin .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5060-5072
[3]   MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes [J].
Angeles Castilla, Maria ;
Diaz-Martin, Juan ;
Sarrio, David ;
Romero-Perez, Laura ;
Angeles Lopez-Garcia, Maria ;
Vieites, Begona ;
Biscuola, Michele ;
Ramiro-Fuentes, Susana ;
Isacke, Clare M. ;
Palacios, Jose .
PLOS ONE, 2012, 7 (10)
[4]   MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets [J].
Baffa, Raffaele ;
Fassan, Matteo ;
Volinia, Stefano ;
O'Hara, Brian ;
Liu, Chang-Gong ;
Palazzo, Juan P. ;
Gardiman, Marina ;
Rugge, Massimo ;
Gomella, Leonard G. ;
Croce, Carlo M. ;
Rosenberg, Anne .
JOURNAL OF PATHOLOGY, 2009, 219 (02) :214-221
[5]   Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen [J].
Bertheau, Philippe ;
Turpin, Elisabeth ;
Rickman, David S. ;
Espie, Marc ;
de Reynies, Aurelien ;
Feugeas, Jean-Paul ;
Plassa, Louis-Francois ;
Soliman, Hany ;
Varna, Mariana ;
de Roquancourt, Anne ;
Lehmann-Che, Jacqueline ;
Beuzard, Yves ;
Marty, Michel ;
Misset, Jean-Louis ;
Janin, Anne ;
de The, Hugues .
PLOS MEDICINE, 2007, 4 (03) :585-594
[6]   Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer [J].
Blick, Tony ;
Hugo, Honor ;
Widodo, Edwin ;
Waltham, Mark ;
Pinto, Cletus ;
Mani, Sendurai A. ;
Weinberg, Robert A. ;
Neve, Richard M. ;
Lenburg, Marc E. ;
Thompson, Erik W. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2010, 15 (02) :235-252
[7]   The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network [J].
Boominathan, Lakshmanane .
CANCER AND METASTASIS REVIEWS, 2010, 29 (04) :613-639
[8]   Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site [J].
Brewster, Brooke L. ;
Rossiello, Francesca ;
French, Juliet D. ;
Edwards, Stacey L. ;
Wong, Ming ;
Wronski, Ania ;
Whiley, Phillip ;
Waddell, Nic ;
Chen, Xiaowei ;
Bove, Betsy ;
Hopper, John L. ;
John, Esther M. ;
Andrulis, Irene ;
Daly, Mary ;
Volorio, Sara ;
Bernard, Loris ;
Peissel, Bernard ;
Manoukian, Siranoush ;
Barile, Monica ;
Pizzamiglio, Sara ;
Verderio, Paolo ;
Spurdle, Amanda B. ;
Radice, Paolo ;
Godwin, Andrew K. ;
Southey, Melissa C. ;
Brown, Melissa A. ;
Peterlongo, Paolo .
HUMAN MUTATION, 2012, 33 (12) :1665-1675
[9]   microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer [J].
Buffa, Francesca M. ;
Camps, Carme ;
Winchester, Laura ;
Snell, Cameron E. ;
Gee, Harriet E. ;
Sheldon, Helen ;
Taylor, Marian ;
Harris, Adrian L. ;
Ragoussis, Jiannis .
CANCER RESEARCH, 2011, 71 (17) :5635-5645
[10]   A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J].
Burk, Ulrike ;
Schubert, Joerg ;
Wellner, Ulrich ;
Schmalhofer, Otto ;
Vincan, Elizabeth ;
Spaderna, Simone ;
Brabletz, Thomas .
EMBO REPORTS, 2008, 9 (06) :582-589